Late Breaking Abstract - Clinical remission with mepolizumab in severe asthma: impact of lung function parameters

被引：1
|
作者：
Oppenheimer, John [1 ]
Carrillo Diaz, Teresa [2 ]
Martinez Moragon, Eva [3 ]
Sanchez Herrero, M. Guadalupe [4 ]
Banas Conejero, David [4 ]
Chupp, Geoffrey [5 ]
Price, Robert G. [6 ]
Raimondi, Alejandro [7 ]
Zhang, Shiyuan [8 ]
Howarth, Peter [9 ]
Domingo Ribas, Christian [10 ]
机构：
[1] Rutgers New Jersey Med Sch, Newark, NJ USA
[2] Univ Las Palmas Gran Canaria, Las Palmas Gran Canaria, Spain
[3] Hosp Univ Dr Peset, Valencia, Spain
[4] GSK, Madrid, Spain
[5] Yale Sch Med, New Haven, CT USA
[6] GSK, Stevenage, Herts, England
[7] GSK, Buenos Aires, DF, Argentina
[8] GSK, Collegeville, PA USA
[9] GSK, Brentford, England
[10] Univ Autonoma Barcelona, Barcelona, Spain
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA646
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA646
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Late Breaking Abstract - BENRALIZUMAB IN SEVERE ASTHMA: PRELIMINARY RESULTS FROM THE ITALIAN ANANKE STUDY
    D'Amato, Maria
    Bracciale, Pierluigi
    Altieri, Elena
    Caiaffa, Maria Filomena
    De Michele, Fausto
    Romagnoli, Micaela
    Ansaldo, Elena
    Canonica, Giorgio Walter
    Pelaia, Girolamo
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [42] Late Breaking Abstract - Masitinib in severe asthma: Results from a randomized, phase 3 trial
    Davidescu, Lavinia
    Chanez, Pascal
    Ursol, Grigoriy
    Korzh, Oleksii
    Deshmukh, Vikranth
    Kuryk, Lesia
    Monja-Marie, Nortje
    Godlevska, Olga
    Devouassoux, Gilles
    Khodosh, Eduard
    Israel, Elliot
    Mansfield, Colin
    Hermine, Olivier
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [43] CLINICAL RESPONSE TO MEPOLIZUMAB IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA
    Harvey, E.
    Langton, D.
    Powell, H.
    Gibson, P.
    RESPIROLOGY, 2019, 24 : 42 - 42
  • [44] CLINICAL EXPERIENCE OF THE USE OF MEPOLIZUMAB IN TREATMENT OF SEVERE ASTHMA
    Syrigos, Nick
    Tsami, Maria
    Psarros, Fotios
    Makris, Michail
    Syrigou, Ekaterini
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB17 - AB17
  • [45] Clinical response to mepolizumab in patients with severe eosinophilic asthma
    Harvey, Erin
    Langton, David L.
    Powell, Heather
    Gibson, Peter G.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [46] Late Breaking Abstract - Preliminary analysis of the data of patients with severe bronchial asthma included in the Russian National Register of Severe Asthma (RSAR)
    Nenasheva, Natalia
    Belevsky, Andrey
    Kravchenko, Natalia
    Avdeev, Sergey
    Emel'Yanov, Aleksandr
    Kurbacheva, Oksana
    Leschenko, Igor
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [47] Late Breaking Abstract - Characteristics of T2-biomarker low severe asthma patients in the UK Severe Asthma Registry (UKSAR)
    Busby, John
    Pfeffer, Paul E.
    Jackson, David J.
    Mansur, Adel H.
    Menzies-Gow, Andrew
    Siddiqu, Salman
    Chaudhuri, Rekha
    Heaney, Liam G.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [48] Late Breaking Abstract-12-month lung clinical and functional consequences in patients with severe COVID-19
    Abdullaeva, Gulnara
    Mustafina, Malika
    Avdeev, Segey
    Gordina, Galina
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [49] Lung function trajectories in a cohort of patients with moderate-to-severe asthma on mepolizumab, omalizumab, or dupilumab
    Nopsopon, Tanawin
    Barrett, Nora A.
    Phipatanakul, Wanda
    Laidlaw, Tanya M.
    Weiss, Scott T.
    Akenroye, Ayobami
    ALLERGY, 2024, 79 (05) : 1195 - 1207
  • [50] Remission outcomes in severe eosinophilic asthma with mepolizumab therapy: Analysis of the REDES study
    Pavord, Ian
    Gardiner, Frances
    Heaney, Liam G.
    Domingo, Christian
    Price, Robert G.
    Pullan, Alison
    Oppenheimer, John
    Brusselle, Guy
    Nagase, Hiroyuki
    Chupp, Geoffrey
    Pizzichini, Emilio
    Banas-Conejero, David
    Howarth, Peter
    FRONTIERS IN IMMUNOLOGY, 2023, 14
12345